AR086525A1 - Metodo de purificacion de anticuerpos - Google Patents

Metodo de purificacion de anticuerpos

Info

Publication number
AR086525A1
AR086525A1 ARP120101815A ARP120101815A AR086525A1 AR 086525 A1 AR086525 A1 AR 086525A1 AR P120101815 A ARP120101815 A AR P120101815A AR P120101815 A ARP120101815 A AR P120101815A AR 086525 A1 AR086525 A1 AR 086525A1
Authority
AR
Argentina
Prior art keywords
solution
buffer
obtaining
acetic acid
nacl
Prior art date
Application number
ARP120101815A
Other languages
English (en)
Inventor
Laure Landric-Burtin
Didier Duthe
Benoit Mothes
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of AR086525A1 publication Critical patent/AR086525A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804Affinity chromatography
    • B01D15/3809Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/165Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

Reivindicación 1: Un método para purificar una proteína de una disolución que comprende: (a) una primera etapa de cromatografía que comprende: pasar dicha disolución sobre una primera columna de cromatografía; eluir un eluyente de proteína cruda de la primera columna de cromatografía usando un primer tampón de elución; y (b) una segunda etapa de cromatografía que comprende: pasar el eluyente de proteína cruda obtenido al final de la etapa (a) sobre una segunda columna de cromatografía; recuperar la proteína purificada de la segunda columna de cromatografía usando un segundo tampón de elusión, en el que cada uno de los tampones comprende Bis Tris.Reivindicación 38: Un método para preparar tampones adecuados para usarse en el método de una cualquiera de las reivindicaciones 1 a 37, que comprende las etapas de: i) crear una disolución con una concentración final de 15 a 25 mM Bis Tris y de 15 a 25 mM NaCl; ii) ajustar el pH de la disolución a un valor comprendido entre 7 y 8 con ácido acético; iii) recoger la mitad de la disolución, obteniendo de esta manera un tampón de equilibrado; iv) ajustar el pH de la mitad restante de la disolución de la etapa (iii) a un valor comprendido entre 4 y 5 con ácido acético; v) recoger la mitad de la disolución obtenida en la etapa (iv), obteniendo de esta manera un tampón de elusión; vi) ajustar el pH de la mitad restante de la disolución de la etapa (v) a un valor comprendido entre 3 y 4 con ácido acético, obteniendo de esta manera un tampón de elusión más; vii) recoger la mitad del tampón de equilibrado obtenido en la etapa (iii) y añadir NaCl para obtener una concentración final de NaCl comprendida entre 0,9 a 1,1 mM, obteniendo de esta manera un tampón de lavado y limpieza. Reivindicación 42: Uso de un tampón que comprende o consiste en Bis Tris, ácido acético, NaCl, y agua para purificar una proteína de una disolución por al menos una etapa de cromatografía.
ARP120101815A 2011-11-23 2012-05-23 Metodo de purificacion de anticuerpos AR086525A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/070768 WO2013075740A1 (en) 2011-11-23 2011-11-23 Antibody purification method

Publications (1)

Publication Number Publication Date
AR086525A1 true AR086525A1 (es) 2013-12-18

Family

ID=46125462

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120101815A AR086525A1 (es) 2011-11-23 2012-05-23 Metodo de purificacion de anticuerpos

Country Status (14)

Country Link
US (2) US10131714B2 (es)
JP (2) JP6437311B2 (es)
KR (1) KR102048598B1 (es)
CN (1) CN104039808B (es)
AR (1) AR086525A1 (es)
AU (2) AU2012342865A1 (es)
BR (1) BR112014012275A2 (es)
CA (1) CA2855491A1 (es)
IL (1) IL232558B (es)
MX (1) MX364908B (es)
RU (1) RU2603347C2 (es)
SG (1) SG11201402410RA (es)
TW (1) TWI643865B (es)
WO (2) WO2013075740A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
HUE038741T2 (hu) * 2013-05-06 2018-11-28 Sanofi Sa Folyamatos többlépéses eljárás antitestek tisztítására
TWI596107B (zh) 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
CN103480346B (zh) * 2013-10-08 2016-04-06 天津工业大学 一种含大环化合物的新型亲和分离材质制备方法及应用
CN104628846B (zh) * 2013-11-06 2019-12-06 三生国健药业(上海)股份有限公司 重组蛋白质的纯化方法
US9725710B2 (en) 2014-01-08 2017-08-08 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US10329323B2 (en) * 2014-07-25 2019-06-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Method for purifying antibodies using PBS
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
JP6783767B2 (ja) * 2014-12-22 2020-11-11 アレクシオン ファーマシューティカルズ インコーポレイテッドAlexion Pharmaceuticals, Inc. 組換えタンパク質を精製する方法
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
CN109071613A (zh) 2016-05-11 2018-12-21 通用电气医疗集团生物工艺研发股份公司 分离基质
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN109311949B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 储存分离基质的方法
WO2017194593A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
US11760777B2 (en) 2017-04-26 2023-09-19 Bristol-Myers Squibb Company Methods of antibody production that minimize disulfide bond reduction
WO2019118921A1 (en) 2017-12-14 2019-06-20 Flodesign Sonics, Inc. Acoustic transducer drive and controller
US11603527B2 (en) * 2017-12-27 2023-03-14 Global Life Sciences Solutions Usa Llc Method and kit for viral vector isolation
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
WO2019217570A1 (en) * 2018-05-08 2019-11-14 Waters Technologies Corporation Methods, compositions and kits useful for ph gradient cation exchange chromatography
EP3636657A1 (en) 2018-10-08 2020-04-15 Ablynx N.V. Chromatography-free antibody purification method
CN113845562A (zh) * 2020-06-28 2021-12-28 佛山汉腾生物科技有限公司 目的蛋白纯化方法
WO2022234412A1 (en) 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins
US20230240961A1 (en) * 2022-01-28 2023-08-03 Praj Industries Limited Process for the preparation of antimalassezia powder

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930008447B1 (ko) * 1987-10-23 1993-09-04 쉐링 코포레이션 단백질 정제방법
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5891741A (en) * 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) * 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
EP2455401B1 (en) 2004-04-21 2018-01-24 The Brigham and Women's Hospital, Inc. Poly-n-acetyl glucosamine (pnag/dpnag)-binding antibodies
JP4831436B2 (ja) 2004-10-21 2011-12-07 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ クロマトグラフィーリガンド
CN107033243B (zh) 2005-03-23 2020-12-15 根马布股份公司 用于治疗多发性骨髓瘤的cd38抗体
CN1814775A (zh) 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (en) * 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
US8399620B2 (en) 2007-07-11 2013-03-19 Novo Nordisk A/S Purification of factor VIII using a mixed-mode or multimodal resin
MY158903A (en) 2007-11-16 2016-11-30 Univ Rockefeller Antibodies specific for the protofibril form of beta-amyloid protein
US20110129468A1 (en) * 2008-02-29 2011-06-02 Biogen Idec Ma Inc. Purified immunoglobulin fusion proteins and methods of their purification
EP2321336A1 (en) 2008-07-18 2011-05-18 Talecris Biotherapeutics, Inc. Method of preparing alpha-1 proteinase inhibitor
EP2360183B1 (en) * 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Antibody purification method by mixed mode chromatography utilizing an arginine-containing loading solution
EP2376523A4 (en) 2009-01-13 2012-11-28 Ge Healthcare Bio Sciences Ab Precipitation of biomolecules with negatively charged polymers
KR101224468B1 (ko) 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
US8536316B2 (en) 2009-08-07 2013-09-17 Emd Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
US9527010B2 (en) 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
WO2011049798A1 (en) 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Use of mixed mode chromatography for the capture and purification of basic antibody products
ES2534936T3 (es) * 2010-08-02 2015-04-30 Ratiopharm Gmbh Método para producir y purificar una sialiltransferasa soluble activa
WO2012125735A1 (en) 2011-03-15 2012-09-20 Abott Laboratories An integrated approach to the isolation and purification of antibodies
ES2784628T3 (es) 2011-03-29 2020-09-29 Glaxosmithkline Llc Sistema de tampón para purificación de proteína
CN103874913B (zh) * 2011-06-17 2017-04-26 罗氏血液诊断股份有限公司 用于生物样品的组织加工的溶液
WO2013028330A2 (en) 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
IN2014CN03555A (es) 2011-10-25 2015-07-03 Onclave Therapeutics Ltd
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method

Also Published As

Publication number Publication date
KR20140094013A (ko) 2014-07-29
CN104039808B (zh) 2019-04-19
CA2855491A1 (en) 2013-05-30
JP2017095505A (ja) 2017-06-01
SG11201402410RA (en) 2014-06-27
RU2014125063A (ru) 2015-12-27
JP2015500798A (ja) 2015-01-08
WO2013075849A1 (en) 2013-05-30
US10131714B2 (en) 2018-11-20
JP6437311B2 (ja) 2018-12-12
BR112014012275A2 (pt) 2017-05-30
MX2014006284A (es) 2014-10-24
IL232558B (en) 2018-08-30
AU2017245478B2 (en) 2019-05-16
TWI643865B (zh) 2018-12-11
AU2012342865A1 (en) 2014-06-19
TW201321402A (zh) 2013-06-01
IL232558A0 (en) 2014-06-30
US20190135942A1 (en) 2019-05-09
WO2013075740A1 (en) 2013-05-30
CN104039808A (zh) 2014-09-10
MX364908B (es) 2019-05-13
US20140323698A1 (en) 2014-10-30
RU2603347C2 (ru) 2016-11-27
AU2017245478A1 (en) 2017-11-02
KR102048598B1 (ko) 2019-11-25

Similar Documents

Publication Publication Date Title
AR086525A1 (es) Metodo de purificacion de anticuerpos
AR121861A2 (es) MÉTODO PARA PREPARAR UNA COMPOSICIÓN DE IgG ENRIQUECIDA A PARTIR DE PLASMA
CY1123952T1 (el) Απομονωση και καθαρισμος αντισωματων αντι-il-13 με την χρηση χρωματογραφιας χημικης συγγενειας πρωτεινης α
ES2492681T3 (es) Método cromatográfico para purificar proteínas que contienen FC
MY144484A (en) Methods of purifying anti a beta antibodies
BR112013030628A2 (pt) "métodos para produção de uma proteína purificada de interesse utilizando uma matriz de cromatografia de afinidade (ca), e de um anticorpo purificado, fragmento de anticorpo ou proteína de fusão de fc utilizando a coluna de proteína a".
PH12013501128A1 (en) Antibody purification by cation exchange chromatography
CU20170039A7 (es) Método de purificación del anticuerpo humanizado 9e4
WO2015191911A3 (en) Protein enriched microvesicles and methods of making and using the same
AR062711A1 (es) Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad
BR112015027812A2 (pt) processo contínuo de multietapa para purificação de anticorpos
ATE526017T1 (de) Abscheidung von polyelektrolyten und reinigung von antikörpern
ATE481482T1 (de) Verfahren zur vorbereitenden rna-reinigung mittels hplc
EA201070987A1 (ru) Очищенные гибридные белки иммуноглобулина и способы их очищения
CL2016001741A1 (es) Método de purificación de conjugados de anticuerpo-fármaco adc mediante cromatografía de interacción hidrofóbica hic que comprende obtener una mezcla de adc en una solución acuosa de sal de 0,2 a 1,5 m, cargar en una columna de hic, recolectar fracción no unida, lavar, y eluir con una solución acuosa de sal de 0 a 0,1 m.
AR062570A1 (es) Proceso para la purificacion de las proteinas que contienen fc
BRPI0607323B8 (pt) composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
BR112012024956A2 (pt) processo para a purificação de uma proteína de fator de crescimento
BR112014000278A2 (pt) método para o preparo de um concentrado de imunoglobulinas polivalentes
BR112013025614A2 (pt) "métodos para purificação de hidrofobina ii e uso de um álcool para purificar a referida hidrofobina".
ATE525466T1 (de) Verfahren und testkit zur trennung, aufreinigung und wiedergewinnung von lang- und kurzkettigen nukleinsäuren
EA201391605A1 (ru) Способы очистки вирусов с использованием гельпроникающей хроматографии
BR112014027994A2 (pt) métodos de cristalização para purificação de anticorpos monoclonais
AR111465A1 (es) Método para la purificación de anticuerpos análogos por el uso de cromatografía de intercambio de cationes
MY157846A (en) Process for the purification of fc-containing proteins

Legal Events

Date Code Title Description
FB Suspension of granting procedure